Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond
Zoledronate (or zoledronic acid) represents a standard (guideline-based) approach in the area of anti-resorptive medication (namely, an annual 15-minute perfusion of 5 mg for os-teoporosis treatment), while the same drug (with doses/regimes variations) is used for other bone metabolic conditions suc...
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Romanian Association of Balneology, Editura Balneara
2024-06-01
|
| coleção: | Balneo and PRM Research Journal |
| Assuntos: | |
| Acesso em linha: | https://bioclima.ro/Balneo704.pdf |